Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cronos Group

MedMen Enterprises Inc.

Brand-name marijuana stocks don't always make for the best investments.

3 Pot Stocks I Wouldn't Buy With Free Money

Canopy Growth's shares have fallen 53% from their 52-week high.

Canopy Growth: Dethroned And Deflated

Darden Restaurants

Seagate Technology Holdings PLC

Guidance, revenue misses, and analyst notes, oh my.

3 Stocks That Stumbled on Thursday

CGC stock is poised to be a long-term winners thanks to deals with Constellation Brands and its acquisition of Acreage Holdings. 
The post 3 Reasons Canopy Growth Stock Should Be a Long-Term Winner appeared first on InvestorPlace.

3 Reasons Canopy Growth Stock Should Be a Long-Term Winner

The cannabis company is burning through its cash reserves at an alarming rate.

Marijuana Stock Canopy Growth Plunges After Analyst Warning

Up in Smoke: The largest cannabis stock may plunge further on $500 million in losses over 2 years.

Canopy Growth Facing Giant Losses

We could be witnessing the start of a powerful comeback in CGC stock. Add Canopy Growth to your portfolio to ride high on the cannabis wave.

Capture the Cannabis Market Momentum with Canopy Growth Stock

Canopy Growth continues to have issues with its leadership transition. Because of this the price of CGC stock has declined.

Leadership Transition Issues Exacerbate to CGC Stock Woes

The U.S.-listed shares of Canopy Growth Corp. CGC, +0.39% WEED, +0.45% edged up 0.3% toward a fourth straight gain in midday trading Wednesday, although Oppenheimer analyst Rupesh Parikh initiated coverage of the Canada-based cannabis company with a not-so-enthusiastic "perform" rating and no price target.

Canopy Growth stock gains again; Oppenheimer initiates at 'perform' with no price target

Canopy Growth stock faces big problems. The company needs to reach $1 billion CAD in sales to break even, but is nowhere near that level.

Canopy Growth Stock Faces Big Problems

CGC stock still isn't a name fit for grandma's safety portfolio, but Canopy Growth may be moving back into a bullish mode.
The post Canopy Growth Stock Emerges as Top Pick appeared first on InvestorPlace.

Canopy Growth Stock Emerges as Top Pick

Canopy Growth has collapsed by over 50% since I last covered the company.

Canopy Growth Has Executed Towards Its Collapse

It's been a wild year for CGC stock, but the next move in Canopy Growth stock will likely be a big rally in 2020. Here's why.

3 Reasons Canopy Growth Stock Could Rally Big in 2020

Canopy Growth's high-margin products coupled with medicinal products will help in EBITDA margin expansion. Near-term cash burn will continue.

Halved from One-Year Highs, Canopy Growth Stock Is Attractive Below $30

Tilray Brands

Investor sentiment toward the cannabis industry can shift quickly.

Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Plunged in August but Rebounded in Early September

Aurora Cannabis

Aphria

HEXO Corp

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Cannabis Short Sellers Hike Their Bets

Bank of America's Canadian cannabis market share study reveals Canopy Growth is an early market leader. The numbers suggest Canopy Growth stock is well-positioned to deliver long-term gains for investors.

Canopy Growth Stock Needs to Be One of Your Main Cannabis Plays

Summer led to a fall, and fall may begin a hard winter for Canopy Growth. For this reason, investors need to reconsider how to invest in CGC stock.

Time to Write Off Canopy Growth Stock in the Short Term

Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.

Keep an Eye on Canopy Growth Stock, but Don’t Buy It Just Yet

Beyond Meat

Etsy

iRobot

Under Armour

Uber

Ulta Beauty

These seven companies were among the worst stocks that crashed and burned this earnings season. But not all hope is lost for some.

7 Worst Stocks That Flopped This Earnings Season

The CEOs of the five biggest Canadian cannabis producers -- and which one looks like the best of the bunch.

Bet on the Jockey? What You'll Want to Know About the Top Canadian Pot Stock CEOs

Canopy Growth shares rebounded slightly in the last week; rebound may follow.

Canopy: 4 Positive Catalysts Ahead

President Trump recently made positive comments about federally legalized cannabis. That’s good news for Canopy Growth and CGC stock.

Why the Future of Canopy Growth Stock Is in the Hands of the President

CGC stock has suffered blow after blow in 2019. But amidst the corporate drama, Canopy's new CFO has a credible plan to get CGC going again.

Canopy Growth’s New CFO Has a Credible Plan to Revive the Company

Cannabis derivative products are on the way in Canada. Here are the most likely winners.

News for Canopy Growth Stock (CGC)